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Thymidylate synthase (TS) enzymes catalyse the biosynthesis of deoxythymidine monophosphate
(dTMP or thymidylate), and so are important for DNA replication and repair. Two different types of
TS proteins have been described (ThyA and ThyX), which have different enzymic mechanisms and
unrelated structures. Mycobacteria are unusual as they encode both thyA and thyX, and the
biological significance of this is not yet understood. Mycobacterium tuberculosis ThyX is thought
to be essential and a potential drug target. We therefore analysed M. tuberculosis thyA and thyX
expression levels, their essentiality and roles in pathogenesis. We show that both thyA and thyX
are expressed in vitro, and that this expression significantly increased within murine macrophages.
Under all conditions tested, thyA expression exceeded that of thyX. Mutational studies show that
M. tuberculosis thyX is essential, confirming that the enzyme is a plausible drug target. The
requirement for M. tuberculosis thyX in the presence of thyA implies that the essential function of
ThyX is something other than dTMP synthase. We successfully deleted thyA from the M.
tuberculosis genome, and this deletion conferred an in vitro growth defect that was not observed
in vivo. Presumably ThyX performs TS activity within M. tuberculosis DthyA at a sufficient rate in
vivo for normal growth, but the rate in vitro is less than optimal. We also demonstrate that thyA
deletion confers M. tuberculosis p-aminosalicylic acid resistance, and show by complementation
studies that ThyA T202A and V261G appear to be functional and non-functional, respectively.
INTRODUCTION
Thymidylate synthase (TS) enzymes catalyse the reductive
methylation of dUMP to synthesize dTMP or thymidylate,
and so are important for DNA replication and repair. Two
different types of TS proteins have been described, which
have different enzymic mechanisms and unrelated struc-
tures, and are therefore thought to have evolved indepen-
dently (Carreras & Santi, 1995; Koehn et al., 2009; Kuhn
et al., 2002; Myllykallio et al., 2002). ThyA (encoded by
thyA), known as the classical or conventional TS, uses
methylene tetrahydrofolate (mTHF) as the methyl donor
and reductant, yielding dihydrofolate (DHF) as a by-
product (Carreras & Santi, 1995). As reduced folate deriva-
tives are essential for a variety of biological processes, DHF
is converted back to tetrahydrofolate (THF) by dihydro-
folate reductase (DHFR; encoded by folA in Escherichia coli
and dfrA in Mycobacterium tuberculosis). The more recently
discovered ThyX (encoded by thyX), known as the alter-
native or flavin-dependent TS, also uses mTHF as the
methyl donor, yielding THF, but uses reduced flavin
adenine dinucleotide (FADH2) as the reductant (Gattis &
Palfey, 2005; Kuhn et al., 2002; Myllykallio et al., 2002). In
both cases THF is converted back to mTHF by serine
hydroxymethyltransferase.
Most organisms contain either thyA or thyX, and a TS-
encoding gene is usually essential (or its deletion creates a
thymidine auxotroph ifthe organism alsoencodesthymidine
kinase). ThyA and ThyX clearly perform the same func-
tion, as complementation experiments show that one can
functionally replace the other. For example, the thymidine
auxotrophy of E. coli lacking thyA can be complemented by
thyX from various organisms, including Helicobacter pylori
(Myllykallio et al., 2002) and Campylobacter jejuni (Giladi
et al., 2002). Also, Halobacterium volcanii thyA can be func-
tionally replaced by Halobacterium salinarum thyX (Giladi
et al.,2 0 0 2 ) .W h e nthyX was deleted from Rhodobacter
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were required for full complementation, although thyA alone
did partially complement the defect (Leduc et al., 2007). This
result is not surprising, as the chemical reaction performed
by ThyA requires high DHFR activity (Giladi et al.,2 0 0 2 ) ,
and most ThyX-dependent bacteria (including R. capsulatus)
do not contain a folA homologue (Leduc et al., 2007;
Myllykallio et al., 2002, 2003).
Corynebacteria (including mycobacteria) are unusual as
they encode both thyA and thyX (and a folA homologue;
Myllykallio et al., 2002), and the biological significance
of this is not yet understood. It is known that both thyA
and thyX from M. tuberculosis (Rengarajan et al., 2004;
Sampathkumar et al., 2005) and Corynebacterium glutami-
cum (Park et al., 2010) can functionally complement an E.
coli thyA deletion strain. ThyA and ThyX from these two
species exhibit 72 and 63% sequence similarity at the
amino acid level, respectively (Kan et al., 2010; Park et al.,
2010). Both M. tuberculosis ThyA and ThyX proteins have
been shown to have TS activity in vitro, with ThyA being
substantially more efficient than ThyX (Hunter et al.,
2008). However, purified C. glutamicum ThyX does not
exhibit any detectable TS activity (Kan et al., 2010).
Mutational studies of C. glutamicum show that thyX is not
essential for in vitro growth, but is thought to play a role in
survival during stationary phase (Park et al., 2010). M.
tuberculosis thyA is not thought to be essential, as thyA
transposon mutants are viable (Sassetti et al., 2003), and
some clinical M. tuberculosis p-aminosalicylic acid (PAS)-
resistant strains contain point mutations within thyA
(Leung et al., 2010; Mathys et al., 2009; Rengarajan et al.,
2004; Zhang et al., 2007). Unlike thyX of C. glutamicum, M.
tuberculosis thyX is thought to be essential (Sassetti et al.,
2003), and there is pharmacological interest in this enzyme
(and ThyX from other pathogenic organisms), as thyX is
absent from the human genome (Myllykallio et al., 2002,
2003). Indeed, the structural, functional and kinetic
analysis of M. tuberculosis ThyX is already under way so
that the rational design of ThyX inhibitors can begin
(Hunter et al., 2008; Sampathkumar et al., 2005, 2006;
Ulmer et al., 2008). This is of importance, as M. tuberculosis
kills approximately two million people annually (WHO,
2009), and no novel antitubercular compound has been
introduced since rifampicin in 1963 (Ahmed & Hasnain,
2004). The increasing incidence of infections with multi-
drug-resistant (MDR) and extensively drug-resistant (XDR)
M. tuberculosisstrains, and theassociated mortalityrates and
high cost of second-line antibiotics, heighten the urgent
demand for compounds with novel modes of action to treat
tuberculosis (Haydel, 2010; Koul et al., 2011; Zignol et al.,
2006).
The main aim of this study was to investigate the biological
roles of M. tuberculosis thyA and thyX by studying their
expression levels, essentiality and roles in pathogenesis, to
establish whether either or both of the enzymes that they
encode are plausible drug targets.
METHODS
Bacterial strains and culture conditions. E. coli strain DH5a
(Invitrogen) was used for all plasmid construction, and strain XL1-
Blue (Stratagene) was used for site-directed mutagenesis (SDM). E.
coli was grown at 37 uC on Luria–Bertani (LB) agar, or in LB broth
with shaking at 250 r.p.m. Where appropriate, E. coli culture media
was supplemented with 100 mg ampicillin ml
21,5 0 mg kanamy-
cin ml
21,2 0mg gentamicin ml
21 and/or 200 mg X-Gal ml
21.
M. tuberculosis H37Rv was used as wild-type and as the parental strain
for deletion strains. M. tuberculosis was usually grown at 37 uCo n
Middlebrook 7H11 agar (Difco) or in modified Dubos medium
(Difco), both supplemented with 4% Dubos Medium Albumin
(Difco) and 0.5 or 0.2% (w/v) glycerol, respectively. However, 7H11
agar was supplemented with 10% Middlebrook oleic acid-albumin-
dextrose-catalase (OADC) enrichment (Difco) and 0.5% (w/v) glyc-
erol when enumerating mycobacterial c.f.u., and the concentration of
albumin was increased to 10% for DthyA liquid cultures due to
bacterial clumping. M. tuberculosis liquid cultures were grown in a
roller incubator at 2 r.p.m. or in an SB3 Tube Rotator (Stewart) at
30 r.p.m. Where appropriate, M. tuberculosis culture medium was
supplemented with 25 mg kanamycin ml
21,1 5mg gentamicin ml
21,
50 mg X-Gal ml
21 and/or 20 mg sucrose ml
21.
Stress exposure. M. tuberculosis H37Rv was grown with rolling at
2 r.p.m. to OD600 ~0.4, and then 25 ml aliquots were placed into six
50 ml Falcon tubes. For oxidative stress, t-butyl hydroperoxide
(TBHP) was added to three cultures to a final concentration of
100 mM, and the other three cultures were untreated controls. For
starvation stress, bacteria were harvested by centrifugation, and three
cultures were resuspended in 16PBS (pH 7.4), while the three
control cultures were resuspended in Dubos medium. For nitrosative
stress, bacteria were harvested and resuspended in acidified Dubos
medium (pH 5.4), and sodium nitrite was added to three cultures to a
final concentration of 2 mM; the remaining three acidified cultures
were controls for nitrosative stress, but also acted as acid-stress
cultures compared with the aforementioned control cultures resus-
pended in non-acidified Dubos medium. Falcon tube cultures were
then incubated for 24 h with rotation at 30 r.p.m., and RNA was
subsequently prepared.
Murine bone marrow-derived macrophages (BMDM) infection
model. Monocytes were isolated from the hind legs of female 6–8
week old BALB/c mice, allowed to differentiate into macrophages for
6 days and flushed from Petri dishes as described elsewhere (Spivey
et al., 2011). Macrophages were seeded into either tissue culture
treated 75 cm
2 flasks (for bacterial RNA isolation) or 24-well plates
(for bacterial survival assays) at a density of 2.6610
6 cells per flask or
2610
5 cells per well. Where appropriate, murine interferon-c (IFN-c;
Roche) was added at a concentration of 10 ng ml
21. Flasks/plates
were incubated at 37 uC with 5% CO2 overnight to allow adherence
and activation. M. tuberculosis cultures were grown to OD600 ~0.5,
and washed once with, and then resuspended in, 16 PBS containing
0.05% Tween 80 (PBS-T). The cells were centrifuged at 300 r.p.m. to
remove any aggregated cells, and an appropriate dilution in PBS-T
was prepared. Macrophages were infected at an m.o.i. of either 5:1 in
flasks or 0.1:1 in wells for 24 or 4.5 h, respectively. After this time the
infected macrophages were washed three times with warm HBSS
(Invitrogen), and fresh medium, with or without 10 ng IFN-c ml
21,
was added as appropriate. Flasks/plates were incubated at 37 uC with
5% CO 2. Mycobacterial RNA was prepared from macrophages in
flasks after a further 24 h incubation, i.e. 48 h post-infection (see next
section). The survival and multiplication of M. tuberculosis were
determined by enumerating c.f.u. within macrophages in wells at
various time points.
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analysis. To isolate mycobacterial RNA from infected BMDM,
medium was removed from the flasks and replaced with two volumes
(26 ml) of guanidine thiocyanate (GTC) solution (4 M GTC, 25 mM
sodium citrate, 0.5% N-laurylsarcosine sodium salt, 0.5% Tween 80
and 100 mM b-mercaptoethanol). Cells were scraped from each flask
with a cell scraper, the solution was poured into a 50 ml Falcon tube,
vortexed vigorously and centrifuged, and RNA was then prepared
from the pellet using a FastRNA Pro Blue kit (Qbiogene).
Additional RNA purification, removal of contaminating DNA,
conversion to cDNA and qRT-PCR were performed as described
previously (Fivian-Hughes & Davis, 2010), except that data were
normalized to rrs (16S rRNA).
Plasmid construction. The plasmids used in this study are listed
and their construction described in Table 1. Primers are listed in
Table 2. SDM was performed using the QuikChange SDM kit
(Stratagene). All plasmids were verified by DNA sequencing.
Creating M. tuberculosis deletion strains. The 59 and 39 flanking
regions of interest were amplified by PCR and were sequentially
cloned into the suicide plasmid pBackbone (Gopaul, 2002), using
restriction enzymes for which sites were incorporated into the
primers. The 6.4 kb sacB/lacZ cassette from pGoal17 (Parish &
Stoker, 2000) was cloned into the unique PacI site of the plasmids.
Deletion plasmids were electroporated into M. tuberculosis H37Rv,
and screening and counter-selection processes were performed as
outlined elsewhere (Parish & Stoker, 2000). Primers were designed
such that 750 bp of the 792 bp thyA gene was deleted, leaving only the
first 32 bp and the last 10 bp, separated by an XbaI site. Likewise,
738 bp of the 753 bp thyX gene was deleted, leaving only the first 4 bp
and the last 11 bp, again separated by an XbaI site.
Southern blotting. Putative M. tuberculosis thyA deletion strains
were confirmed by Southern blot analysis performed as described
previously (Fivian-Hughes & Davis, 2010), except that genomic DNA
was digested with PstI, and the probe consisted of a 240 bp PCR
product generated from primers thyA probeF and thyA probeR.
Assessing in vitro growth. M. tuberculosis strains were grown with
rolling at 2 r.p.m. to OD600 ~0.5. These cultures were used to inoculate
fresh media to OD600 ~0.02, and the OD600 was then monitored for
14 days.
Mouse infection studies. M. tuberculosis strains were prepared as
for macrophage infections, except that the final resuspension in
PBS did not contain Tween 80. Female 6–8 week old BALB/c mice
were injected intravenously with approximately 1610
6 bacteria. The
survival and multiplication of M. tuberculosis were determined by
enumerating c.f.u. within the lungs and spleens of four mice at each
time point.
Assessing PAS susceptibility. M. tuberculosis strains were grown
with rotation at 30 r.p.m. to OD600 ~0.4. Cultures were serially
diluted in PBS-T and were plated onto agar containing 0, 0.1, 1, 10 or
100 mg PAS ml
21. c.f.u. were enumerated and percentage survival
relative to untreated samples was calculated.
RESULTS
thyA is expressed at a higher level than thyX
Earlier microarray analysis suggested that M. tuberculosis
thyX mRNA was undetectable during both in vitro and in
Table 1. Plasmids used in this study
Kanamycin
R and ampicillin
R, kanamycin and ampicillin resistance, respectively.
Name Description and construction Reference or source
pBackbone Mycobacterial suicide vector (kanamycin
R and ampicillin
R) Gopaul (2002)
pGoal17 Plasmid containing the sacB/lacZ cassette (ampicillin
R) Parish & Stoker (2000)
pKP186 Integrating mycobacterial cloning vector that does not contain integrase (kanamycin
R) Rickman et al. (2005)
pKP203 pKP186 derivative with a gentamicin-resistance cassette replacing the kanamycin-resistance cassette Rossi et al. (2005)
pBS-Int Mycobacterial suicide vector containing integrase (ampicillin
R), electroporated in conjunction with
pKP186 and its derivatives
Springer et al. (2001)
pJH-thyX thyX deletion plasmid; pBackbone containing thyX 59 and 39 flanking regions, and the sacB/lacZ
cassette*
This study
pJH-thyA thyA deletion plasmid; pBackbone containing thyA 59 and 39 flanking regions, and the sacB/lacZ
cassette*
This study
pASF59 thyX complementation plasmid; pKP203 containing thyX, including 523 bp upstream and 53 bp
downstream of the annotated gene. The 1375 bp PCR product from primers thyXcompF and
thyXcompR was inserted into PvuII
This study
pASF63 thyA complementation plasmid; pKP186 containing thyA, including 340 bp upstream and 110 bp
downstream of the annotated gene. The 1249 bp PCR product from primers thyAcompF and
thyAcompR was cloned into BamHI and NotI
This study
pASF70 pASF63 derivative containing the T202A (ACCAGCC) mutation in thyA; SDM primers
T202A F and T202A R were used
This study
pASF71 pASF63 derivative containing the V261G (GTCAGGC) mutation in thyA; SDM primers
V261G F and V261G R were used
This study
*Construction of deletion plasmids involved multiple cloning steps (refer to Methods).
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to study in vitro expression levels of thyA and thyX using
qRT-PCR, which is a more sensitive technique than micro-
array technology. Both thyA and thyX were detectable by
qRT-PCR from M. tuberculosis H37Rv grown to exponen-
tial phase (Fig. 1a). The expression of both of these genes
was significantly reduced upon reaching stationary phase
(Fig. 1a), as one might expect when the DNA replication
rate is lower, to the point that thyX was undetectable.
Interestingly, thyA expression was significantly higher than
thyX expression in both growth phases (Fig. 1a; Student’s t
tests, P,0.05 and P,0.01 for exponential and stationary
phase, respectively), yet thyX is the gene predicted to be
essential (Sassetti et al., 2003).
It has been postulated that mycobacteria might preferen-
tially use ThyA or ThyX under different growth conditions
(Sampathkumar et al., 2005). We therefore assessed thyA
and thyX expression after 24 h exposure to various in vitro
stresses, in search of a condition where thyX expression
might be increased. Expression of thyA was significantly
decreased by 2.4-fold upon both oxidative and nitrosative
stress, and was significantly increased by 2.9-fold upon acid
stress, when compared with appropriate controls (Fig. 1b).
Expression of thyX was significantly decreased by 3.2-fold
upon starvation, and was significantly increased by 1.6-fold
upon acid stress (Fig. 1b). For all of the in vitro growth
conditions tested, thyA expression remained significantly
higher than that of thyX (Fig. 1b; Student’s t tests, P,0.01
for all test conditions except TBHP, where P,0.05).
It should be noted that the exponential phase cultures in
Fig. 1(a) are essentially the same as the untreated cultures
in Fig. 1(b), but thyA expression is significantly lower in
Fig. 1(b) (Student’s t test, P50.01). This may be due to the
level of culture aeration, as 50 ml cultures were grown in
1 l bottles with rolling at 2 r.p.m. for the experiment
shown in Fig. 1(a), while the data shown in Fig. 1(b) were
obtained from 25 ml cultures incubated in 50 ml Falcon
tubes rotating at 30 r.p.m. (see Methods). It is not known
why the level of aeration would have this effect on thyA
expression.
thyA and thyX expression significantly increases
during macrophage infection
To investigate whether thyA or thyX expression is altered in
vivo, M. tuberculosis H37Rv was used to infect murine
Table 2. Primers and oligonucleotides used in this study
Name Sequence (5§–3§)
16srRNAF* AAGAAGCACCGGCCAACTAC
16srRNAR* TCGCTCCTCAGCGTCAGTTA
thyA qF* TGCACGAGCACGGAGTCA
thyA qR* CCCGAGTTCGCCTGTATCAC
thyX qF* GCTACCTCCGGCACATCATC
thyX qR* GACACGCTGGCATGCTCTAG
dfrA qF* CCGGCGAAATGTCGTACTG
dfrA qR* CTCCTCGAGTGAACCGACAAC
thyX 59 For GACTGCGGCCGCAACGAGGAAGAC
thyX 59 Rev GGTCTAGACCACGGCGCTCACCTTAG
thyX 39 For GTGGCGACCAGCCCGTTCTAGACCGAAG
thyX 39 Rev GGCCACCCTTTGGGGATCCTTTAGA
thyXcompF GGGAGCAACTGCGGCCGCTTAGATG
thyXcompR GACGGTGGTCACGGATCCCAAGGTTAC
thyX CheckF CGGCCGAAGGAATGGAGGAGT
thyX CheckR GGCGACGGCGGTGAAATG
thyA 59 For GTGGAAAGTGAGCTCACGCACTGC
thyA 59 Rev GTTTCTAGAACGAAGCGCAGCAGGTCC
thyA 39 For GATCAAAGCTCTAGACGCGGTAT
thyA 39 Rev AAGTCGAGATGGATCCCTAGCCTTACCT
thyA probeF CGCGCCGACGACAATGAA
thyA probeR GCAGCGGCCGGACTTTAGC
thyAcompF GCGGTAGTACACGTCGGGATCCAGAAC
thyAcompR CCGCCGCGGCCGTGACAC
T202A F GGTCGGCGAGTTCATCTGGGCCGGTGGCGACTGCCACATC
T202A R GATGTGGCAGTCGCCACCGGCCCAGATGAACTCGCCGACC
V261G F CCGGCGATCAAAGCTCCAGGCGCGGTATGAGGCGCGCCG
V261G R CGGCGCGCCTCATACCGCGCCTGGAGCTTTGATCGCCGG
*qRT-PCR primers.
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isolated 48 h post-infection using a solution containing
GTC (see Methods). GTC solution lyses the macrophages
and stabilizes the mycobacterial RNA, thus allowing the
separation of bacteria from the macrophage lysate without
compromising the mycobacterial RNA (Butcher et al.,
1998). No thyA or thyX expression was detected during
preliminary qRT-PCR experiments using uninfected mac-
rophages (data not shown), indicating either that host
RNA was absent or that any contaminating host RNA
could not be amplified with the mycobacterial-specific
primers. Expression of thyA and thyX was significantly
increased within both naive and IFN-c-activated macro-
phages, when compared with in vitro exponential expres-
sion levels (by 4.0-fold and 4.4-fold for thyA, and 7.9-fold
and 8.0-fold for thyX, respectively; Fig. 1c). However, thyA
expression remained significantly higher than thyX expres-
sion within both naive and activated macrophages (Fig. 1c;
Student’s t tests, P,0.01).
thyX (Rv2754c) is essential
thyX (Rv2754c) was targeted for in-frame deletion within
M. tuberculosis, as RT-PCR indicated that it is co-
transcribed with its downstream genes dapA (Rv2753c)
and Rv2752c (Fig. 2a; data not shown). After electropora-
tion of pJH-thyX into M. tuberculosis H37Rv, potential
single cross-over recombinants were analysed by PCR
(results not shown), to ensure that integration within the
strain taken forward had occurred at the correct locus.
Upon selection, no double cross-over strains, i.e. thyX
deletion strains, were obtained under normal conditions,
or in the presence of 50, 100 or 500 mg thymidine ml
21 (all
colonies obtained or 36 colonies were analysed by PCR for
each condition; data not shown). This suggests that thyX is
essential for the survival of M. tuberculosis, even in the
presence of thyA and exogenous thymidine.
Toconfirmessentiality,anadditionalcopyofthyXexpressed
from its own promoter (on pASF59) was integrated into
the att site of the thyX single cross-over strain, creating
a merodiploid strain. Empty vector (pKP203) was also
independently integrated into the same single cross-over
strain. Upon selection, the wild-type copy of thyX was
successfully deleted in the presence of pASF59 (11 out of 36
colonies analysed by PCR), but not in the presence of empty
vector (0 out of 36 colonies analysed by PCR), confirming
that thyX is essential under the conditions used (Fig. 2b).
The addition of 100 mg thymidine ml
21 had no effect on the
Fig. 1. In vitro and in vivo expression levels of thyA and thyX. qRT-
PCR was performed on RNA extracts of M. tuberculosis H37Rv (a)
grown to exponential and stationary phases (OD600 0.8 and 4.0,
respectively), (b) after 24 h exposure to different stress conditions
and (c) after 48 h intracellular growth within murine BMDM. The
data are means of at least three biological replicates or at least six
infections (each assayed in triplicate), normalized to corresponding
rrs (16S rRNA) values; error bars, SD. Oxidative stress was
modelled using 100 mM TBHP, and untreated cultures acted as
controls. Starvation and acid stress were modelled by resuspend-
ing cells in PBS or acidified media (pH 5.4), respectively, and
cells resuspended in media (Media) acted as control cultures.
Nitrosative stress was modelled by resuspending cells in acidified
media containing 2 mM sodium nitrite, and cells resuspended in
acidified media acted as control cultures. Significant differences in
thyA or thyX expression from equivalent exponential phase or
appropriate control levels are indicated (* or **; Student’s t test,
P,0.05 or P,0.01, respectively).
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these strains (data not shown), supporting the hypothesis
that M. tuberculosis cannot utilize exogenous thymidine
because its genome does not encode thymidine kinase
(Myllykallio et al., 2002).
thyA (Rv2764c) is not essential
thyA (Rv2764c) was targeted for in-frame deletion within
M. tuberculosis, as RT-PCR indicated that it is co-
transcribed with its downstream genes dfrA (Rv2763c)
and Rv2762c (Fig. 2a; data not shown). We did not assess
whether this transcript extends beyond Rv2762c, so it
remains possible that thyA-Rv2757c forms a single operon.
Strains containing the thyA deletion were isolated; five of
the 28 white, sucrose-resistant, kanamycin-sensitive col-
onies analysed by PCR gave the products expected for the
thyA deletion (results not shown), and three of these were
further confirmed by Southern blotting (Fig. 2c, d).
M. tuberculosis thyA deletion strain 1 from Fig. 2(d),
designated DthyA, was used for all further experiments.
thyA deletion confers an in vitro growth defect
An immediate growth defect was seen when attempting to
grow M. tuberculosis DthyA with rolling at 2 r.p.m. in
modified Dubos medium [containing 4% albumin and
0.2% (w/v) glycerol]. The strain grew noticeably more
slowly than wild-type H37Rv and began to clump at OD600
~0.5. Upon increasing the albumin concentration within
the medium to 10%, DthyA no longer clumped and so it
was possible to produce growth curves, alongside H37Rv
and the complemented strain (DthyA containing pASF63).
The OD600 of M. tuberculosis DthyA differed significantly
from that of wild-type H37Rv at four of the seven time
points (Fig. 3). M. tuberculosis DthyA appears to have a
prolonged lag phase compared with wild-type H37Rv, and
this growth defect was restored to the wild-type phenotype
in the complemented strain (Fig. 3). The addition of
thymidine (100 mgm l
21) did not have any effect on the
growth of these three strains (results not shown), again
supporting the hypothesis that M. tuberculosis cannot
utilize exogenous thymidine. From this point onward, all
liquid media contained 10% albumin.
Fig. 2. Deletion of thyX and thyA from the M. tuberculosis genome. (a) Schematic diagram showing the relative locations of thyX
and thyA within the M. tuberculosis H37Rv genome (adapted from TubercuList; http://genolist.pasteur.fr/TubercuList/). (b)
PCR analysis for the thyX deletion within 36 colonies selected from the thyX single cross-over strain either with (pASF59) or
without (pKP203) an additional copy of thyX present. The primers (thyX CheckF and thyX CheckR) span the thyX genomic
region and so yielded a smaller-sized product upon thyX deletion (2427 bp) when compared with wild-type (3159 bp).
Colonies 31 and 34 for pASF59 were later shown to be wild-type at the thyX locus using the same primers. +, Wild-type
H37Rv positive controls; ”, distilled H2O negative controls. The marker is the upper half of Hyperladder I (Bioline). (c)
Schematic diagram showing the region of thyA that was deleted and the locations of the PstI sites and the probe used for
Southern blotting. (d) Southern blot analysis of three independently generated M. tuberculosis thyA deletion strains (1–3)
alongside wild-type H37Rv (WT). The PstI site within thyA of the wild-type strain is absent within the three deletion strains, and
so a larger-sized product was detected (9171 bp compared with 5401 bp).
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Infection models were utilized to assess the effect of thyA
deletion on in vivo growth. M. tuberculosis H37Rv and
DthyA were used to infect murine BMDM (at an m.o.i. of
0.1:1 for 4 h) and immunocompetent BALB/c mice
(intravenously). Bacteria within macrophages and within
the lungs and spleens of mice were enumerated at various
time points post-infection to assess the survival and
multiplication of each strain. Although the quantity of
M. tuberculosis DthyA within naive macrophages differed
significantly from equivalent wild-type H37Rv numbers at
later time points (Fig. 4a), this was not the case in the
activated macrophage and mouse model analysis (Fig. 4a,
b). Therefore, we concluded that the deletion of thyA does
not affect M. tuberculosis in vivo growth.
thyX expression is not elevated to compensate for
the loss of thyA
As our studies had shown that the expression of thyX was
much lower than that of thyA under allconditions tested, yet
it was possible to delete thyA we wondered whether the
expression of thyX might be elevated in the thyA deletion
strain as a means of compensating for its absence. To assess
this, the relative expression levels of thyA, dfrA and thyX
within M. tuberculosis H37Rv, DthyA and the complemented
strain were quantified by qRT-PCR (Fig. 5). The results
confirmed that there was significantly less thyA expression
within M. tuberculosis DthyA when compared with wild-type
H37Rv levels, and that thyA expression was restored to wild-
type levels within the complemented strain. Furthermore,
dfrA expression was unaffected by thyA deletion, so the
deletion does not appear to have resulted in downstream
polar effects. Importantly, the expression of thyX was also
unchanged in the thyA deletion strain. This suggests that
although both M. tuberculosis ThyA and ThyX proteins are
known to have TS activity in vitro (Hunter et al., 2008), thyX
expression is not upregulated to compensate for the lack of
thyA expression.
thyA deletion confers PAS resistance
As some clinical M. tuberculosis PAS-resistant strains have
mutations within thyA (Leung et al., 2010; Mathys et al.,
2009; Rengarajan et al., 2004; Zhang et al., 2007), we
investigated whether thyA deletion confers PAS resistance.
Briefly, cultures were grown to exponential phase and
plated onto agar containing increasing concentrations of
PAS (up to 100 mgm l
21). The percentage survival of each
strain for each PAS concentration was then calculated
compared with that of cells plated without any PAS. The
survival of M. tuberculosis DthyA was significantly greater
than that of wild-type H37Rv at all concentrations ¢1 mg
PAS ml
21, and this phenotype was restored to wild-type in
the complemented strain (Fig. 6). Therefore, thyA deletion
confers PAS resistance.
T202A and V261G mutations, associated with
clinical PAS resistance, render ThyA functional
and non-functional, respectively
To further investigate the relationship between ThyA and
PAS activity, we analysed the effect of complementing M.
tuberculosis DthyA with thyA containing mutations asso-
ciated with PAS resistance. The thyA T202V (ACCAGCC)
and V261G (GTCAGGC) mutations have been identified
within some clinical M. tuberculosis PAS-resistant strains,
and are thought to affect the structural stability and active
catalytic site of the enzyme, respectively (Leung et al., 2010;
Mathys et al., 2009; Rengarajan et al., 2004; Zhang et al.,
2007). These mutations were independently introduced
into the thyA complementation plasmid pASF63 by SDM,
yielding pASF70 and pASF71, respectively. M. tuberculosis
DthyA complemented with thyA T202A (pASF70) was able
to restore the in vitro growth defect of the deletion
strain back to the wild-type phenotype, while the strain
complemented with thyA V261G (pASF71) retained the
growth defect of the deletion strain (data not shown). In
addition, thyA T202A was able to complement the PAS
resistance seen for the deletion strain, while thyA V261G
could not (Fig. 6). qRT-PCR analysis showed that the
introduction of these mutations had no effect on the thyA
transcription level from the complementation plasmid
(data not shown). Therefore, ThyA T202A appears to be
functional and ThyA V261G appears to be non-functional.
It seems that functional ThyA is required for M. tuber-
culosis to be sensitive to PAS.
Fig. 3. In vitro growth of M. tuberculosis DthyA. In vitro growth
curves of M. tuberculosis H37Rv, DthyA and the complemented
strain (DthyA containing pASF63). Strains were grown in modified
Dubos medium containing 10% albumin and 0.2% (w/v) glycerol.
The data are means of three biological replicates; error bars, SD.
The wild-type H37Rv and complemented strain curves overlap.
Times when the OD600 of M. tuberculosis DthyA was significantly
lower than that of wild-type H37Rv and the complemented strain
are indicated (*; Student’s t test, P,0.01).
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To gain insight into the biological roles of M. tubercu-
losis thyA and thyX, we first analysed the in vitro and in
vivo expression levels of these two genes by qRT-PCR. Con-
trary to earlier microarray analysis (Talaat et al., 2004),
expression of both thyA and thyX was detected. Under
all conditions tested, thyA expression exceeded that of
thyX. We were unable to identify a condition where thyX
expression alone was increased. However, expression of
both genes significantly increased upon in vitro acid
exposure (pH 5.4) and when grown within naive and
activated murine macrophages, so both ThyA and ThyX
may play an important role in vivo. To our knowledge only
one other study has shown that thyA is upregulated in vivo
(within THP-1 human macrophages; Fonta ´n et al., 2008),
while Schnappinger et al. (2003) showed that thyA and
thyX expression was unchanged in murine macrophages.
Again, this illustrates that interesting observations can
sometimes be missed when using microarray technology.
Microarrays suffer from inherent relatively large variability
in expression levels for genes expressed at low levels,
meaning that the expression changes of these genes are not
shown to be significantly different (Butte, 2002; Chuchana
et al., 2007).
In agreement with transposon site hybridization (TraSH)
experiments (Sassetti et al., 2003), we showed that M.
tuberculosis thyX is essential on solid media in vitro. The
requirement for thyX in the presence of thyA implies that
the essential function of ThyX is something other than
dTMP synthase. Earlier studies have indeed questioned
whether the true biological substrates of ThyX have been
identified, as many of these enzymes (including ThyX from
M. tuberculosis and C. glutamicum) have very low TS
catalytic activity (Agrawal et al., 2004; Hunter et al., 2008;
Kan et al., 2010). It should be noted that thyX from C.
glutamicum is only thought to be essential upon reaching
stationary phase (Park et al., 2010), and so the biological
roles of ThyX appear to differ between these two relatively
closely related species. Importantly, we have shown that
this enzyme is a plausible tuberculosis drug target, and our
collaborators have recently published their findings that
compounds specifically designed to inhibit M. tuberculosis
ThyX are effective, with no activity against ThyA (Ko ¨gler
et al., 2011). It would be of great interest to identify the
Fig. 4. In vivo growth of M. tuberculosis DthyA. Growth of M. tuberculosis H37Rv and DthyA was assessed within (a) murine
BMDM (alongside the complemented strain; DthyA containing pASF63) and (b) BALB/c mice. The data are means of three
macrophage infections or the lungs and spleens of four mice; error bars, SD. Times when the quantity of M. tuberculosis DthyA
was significantly different from that of wild-type H37Rv are indicated (* or **; Student’s t test, P,0.05 or P,0.01, respectively).
thyX is essential and DthyA is PAS-resistant
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this could possibly be achieved using a metabolomics
approach (de Carvalho et al., 2010).
We successfully deleted thyA from the M. tuberculosis
genome, and this deletion was shown to confer an in vitro
growth defect that was not observed in vivo. M. tubercu-
losis has evolved to grow within its human host, and
culture medium is a very unnatural environment for the
bacterium. The murine macrophage and animal models
used within this study are much more representative of the
natural M. tuberculosis environment. The in vitro experi-
ments do support the hypothesis that M. tuberculosis
cannot utilize exogenous thymidine because its genome
does not encode thymidine kinase (Myllykallio et al.,
2002). It therefore appears as though ThyX performs TS
activity within M. tuberculosis DthyA at a rate sufficient for
normal growth in vivo, but that the rate in vitro is less than
optimal. This could be due to a change in the thyX
transcription rate and/or ThyX TS activity. We have
already shown that M. tuberculosis thyX mRNA levels are
higher in vivo than in vitro. Also, Campylobacter jejuni
ThyX is known to be inhibited by oxygen (Giladi et al.,
2002), so M. tuberculosis ThyX may be more active in vivo
under conditions of limited oxygen availability than in
vitro. The in vitro expression level of thyX is unchanged
within M. tuberculosis DthyA, indicating that the transcrip-
tional regulation of the two TS genes is probably not
linked. It would be interesting to know whether thyX
is actually essential for in vivo growth. This could be
investigated by switching (Pashley & Parish, 2003) the
existing complementation plasmid within a strain where
wild-type thyX was successfully deleted, with a plasmid
expressing thyX from a regulated promoter. The strain
could then be grown in vitro with thyX being expressed and
subsequently used to infect macrophages or mice without
thyX expression (Boldrin et al., 2010; Carroll et al., 2005;
Guo et al., 2007). Unfortunately, these experiments are
beyond the scope of this study.
Some clinical M. tuberculosis PAS-resistant strains contain
point mutations within thyA (Leung et al., 2010; Mathys
et al., 2009; Rengarajan et al., 2004; Zhang et al., 2007). We
have conclusively demonstrated that thyA deletion confers
M. tuberculosis PAS resistance. We also showed that ThyA
T202A appears to be functional and ThyA V261G appears
to be non-functional. This finding is supported by a recent
study which demonstrated that the thyA T202A mutation is
a marker for the Latin American Mediterranean lineage of
M. tuberculosis and is not associated with PAS resistance
(Feuerriegel et al., 2010). The mode of action of PAS is
currently unknown. PAS has structural similarities to
sulphonamides, which act as competitive inhibitors of
dihydropteroate synthase (FolP1 and FolP2), and dihy-
dropteroate is a precursor of DHF. However, PAS appears
to be a poor inhibitor of M. tuberculosis FolP1 in vitro
(Nopponpunth et al., 1999), and mutations within M.
tuberculosis folP1 and folP2 have not been found to be
associated with PAS resistance (Mathys et al., 2009). It
has been suggested that PAS may be a pro-drug whose
activation requires viable ThyA (Mathys et al., 2009;
Fig. 5. thyA, dfrA and thyX expression levels in M. tuberculosis
DthyA. qRT-PCR was performed on RNA extracts of M.
tuberculosis H37Rv, DthyA and the complemented strain (DthyA
containing pASF63), grown to exponential phase (OD600 0.8). The
data are means of at least three biological replicates (each
assayed in triplicate), normalized to corresponding rrs (16S rRNA)
values; error bars, SD. Only the expression level of thyA was
significantly lower within M. tuberculosis DthyA compared with
equivalent wild-type H37Rv and complemented strain levels (*;
Student’s t test, P,0.01).
Fig. 6. PAS susceptibility of M. tuberculosis DthyA and the effects
of complementing with mutated versions of thyA. PAS suscept-
ibility of M. tuberculosis H37Rv, DthyA and three complementing
strains, presented as percentage survival relative to untreated
samples. The complemented strain (DthyA containing pASF63)
expressed wild-type thyA, while T202A and V261G (DthyA
containing pASF70 and pASF71, respectively) expressed the
indicated mutated versions of thyA. The data are means of three
biological replicates; error bars, SD. An asterisk indicates that the
percentage survival of a particular strain was significantly greater
than that of the wild-type H37Rv (*; Student’s t test, P,0.02).
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316 Microbiology 158Rengarajan et al., 2004), but only approximately 36% of
clinical and spontaneous M. tuberculosis PAS-resistant
strains have mutations in thyA (Mathys et al., 2009;
Zhang et al., 2007). Also, Mycobacterium bovis BCG thyA
mutations confer resistance to 8710, a trimethoprim
analogue that antagonizes mycobacterial DHFR, in addi-
tion to PAS (Rengarajan et al., 2004). Therefore, PAS
appears to target an unknown component of folate
biosynthesis, and as ThyA is a major consumer of THF,
strains mutated in thyA are able to withstand the pressure
on the folate cycle (Leduc et al., 2007; Rengarajan et al.,
2004). Nevertheless, thyA sequencing has proved effective
at predicting PAS treatment outcome (Leung et al., 2010).
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